Gufic BioSciences Limited (GUFICBIO):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Gufic BioSciences Limited (GUFICBIO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH82921FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Gufic BioSciences Limited (Gufic) is a generic pharmaceutical company. It carries out development, manufacturing and marketing of pharmaceutical, generics, herbal, API’s and healthcare products. The company’s product portfolio includes ridol, optifer, lotril, rabol plus, shapers, stretch nil, livpar, sallaki, eugynin, zulcer and others. Its products find application in various therapeutic segments including anti-infectives, orthopaedic disorders, gynaecological disorders, and gastrointestinal disorders. The company’s products are used in treatment of diseases such as diarrhea, iron deficiency anemia, bacterial infections, indigestion, acute and chronic pain, dyspepsia and diabetis, among others. Gufic offers products in various formulations including tablets, capsules, ointments, syrups and suspensions, injections, powders, and lotions. Gufic is headquartered in Mumbai, Maharashtra, India.

Gufic BioSciences Limited Key Recent Developments

Feb 14, 2013: Gufic BioSciences Reports Revenue Of INR246.2m In Q3 Fiscal 2013

This comprehensive SWOT profile of Gufic BioSciences Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Gufic BioSciences Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Gufic BioSciences Limited – Key Information
Gufic BioSciences Limited – Overview
Gufic BioSciences Limited – Key Employees
Gufic BioSciences Limited – Key Employee Biographies
Gufic BioSciences Limited – Key Operational Heads
Gufic BioSciences Limited – Major Products and Services
Gufic BioSciences Limited – History
Gufic BioSciences Limited – Company Statement
Gufic BioSciences Limited – Locations And Subsidiaries
Gufic BioSciences Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Gufic BioSciences Limited – Business Description
Gufic BioSciences Limited – Corporate Strategy
Gufic BioSciences Limited – SWOT Analysis
SWOT Analysis – Overview
Gufic BioSciences Limited – Strengths
Gufic BioSciences Limited – Weaknesses
Gufic BioSciences Limited – Opportunities
Gufic BioSciences Limited – Threats
Gufic BioSciences Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Gufic BioSciences Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Gufic BioSciences Limited, Key Information
Gufic BioSciences Limited, Key Ratios
Gufic BioSciences Limited, Share Data
Gufic BioSciences Limited, Major Products and Services
Gufic BioSciences Limited, History
Gufic BioSciences Limited, Key Employees
Gufic BioSciences Limited, Key Employee Biographies
Gufic BioSciences Limited, Key Operational Heads
Gufic BioSciences Limited, Other Locations
Gufic BioSciences Limited, Subsidiaries
Gufic BioSciences Limited, Key Manufacturing facilities
Gufic BioSciences Limited, Key Competitors
Gufic BioSciences Limited, SWOT Analysis
Gufic BioSciences Limited, Ratios based on current share price
Gufic BioSciences Limited, Annual Ratios
Gufic BioSciences Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Gufic BioSciences Limited, Performance Chart
Gufic BioSciences Limited, Ratio Charts

★海外企業調査レポート[Gufic BioSciences Limited (GUFICBIO):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Niko Resources, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Niko Resources, Ltd. Mergers an …
  • PharmaCyte Biotech Inc (PMCB):企業財務及び戦略的SWOT分析
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex, Inc. is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company develops Cell-in-a-Box cellulose-based live cell encapsulation technology. Its technology is used for the tre …
  • Telecom Italia S.p.A.:企業の戦略・SWOT・財務分析
    SummaryTelecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Waterstone Financial, Inc. (WSBF):企業の財務及び戦略的SWOT分析
    Waterstone Financial, Inc. (WSBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Westell Technologies, Inc. (WSTL):企業の財務及び戦略的SWOT分析
    Summary Westell Technologies, Inc. (Westell) is a communication service company that designs and distributes networking and high speed transmissions products. The company’s products include in-building wireless, intelligent site management, cell site optimization, and outside plant and industrial ne …
  • Mediclin AG (MED):企業の財務及び戦略的SWOT分析
    Summary Mediclin AG (Mediclin) is a healthcare service provider that offers rehabilitation and medical care services. The center’s rehabilitation services include structured planning, Internal medicine, and orthopaedics and trauma rehabilitation. It provides treatment for eating disorders, age psych …
  • Zeltia S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Zeltia S.A. Mergers and Acquisi …
  • Abington Resources Ltd. (ABL):企業概要、財務及び戦略的SWOT分析
    Summary Abington Resources Ltd. (Abington) is an oil and gas service provider. The company acquires, explores and develops oil and gas and mineral properties in Western Canada. Its properties include Juniper Property and the Kingsford and Weyburn Oil Properties. The company’s Kingsford and Weyburn o …
  • Electricity Authority of Cyprus:企業の戦略的SWOT分析
    Electricity Authority of Cyprus - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Stanley Electric Co., Ltd. (6923):企業財務及び戦略的SWOT分析
    Summary Stanley Electric Co., Ltd. (Stanley) is an equipment manufacturer that develops and offers automobile and electronic equipment. The company provides automobile equipment and electronic equipment. Its automobile equipment includes four-wheeled motor vehicle parts, two-wheeled motor vehicle pa …
  • Soluble Systems, LLC:(医療機器分野)企業M&A及び提携動向
    Summary Soluble Systems, LLC (Soluble Systems) is a medical device company. The company manufactures and markets wound care products used in the treatment of chronic wounds. It offers its products under the brand names, TheraSkin and TheraGauze. Soluble Systems' TheraSkin is a biologically active hu …
  • Biocartis SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Biocartis SA Mergers and Acquis …
  • MPI Research(製薬・医療分野):企業M&A動向
    Summary MPI Research (MPI) is a contract research company. The company provides preclinical and early clinical research services. Its services include drug metabolism research, in vitro services, research models, medical device evaluation, radiochemistry laboratory, pharmacology, discovery diagnosti …
  • Teledyne Scientific and Imaging, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Teledyne Scientific and Imaging …
  • Astellas Pharma US, Inc.(製薬・医療分野):企業M&A動向
    Summary Astellas Pharma US, Inc. (Astellas Pharma) is a pharmaceutical company. The company manufactures and distributes pharmaceutical products. Its products include adenosine injection, regadenoson injection, tacrolimus ointment, tacrolimus capsules and injection, tacrolimus extended-release capsu …
  • Purfresh, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Purfresh, Inc. Mergers and Acqu …
  • Abdullah Al-Othaim Markets Co.:戦略・SWOT・企業財務分析
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Edge Resources Inc. (EDE):企業概要、財務及び戦略的SWOT分析
    Summary Edge Resources Inc. (Edge Resources) is an oil and gas company. It undertakes acquisition, exploration, production and development of oil and natural gas. The company focuses on bespoke geological mapping, drilling, and differentiated FRAC technique. The projects taken up by the company are …
  • EDF Trading Limited:企業のM&A・提携動向(石油・ガス分野)
    Summary EDF Trading Limited (EDF), a subsidiary of Electricite de France S.A. is an oil and gas company that provides wholesale energy marketing services. The company offers various commodities such as electricity, gas, liquefied natural gas, coal and freight; carbon, green energy, biogas and others …
  • Shanxi Sanwei Group Co., Ltd (000755):企業の財務及び戦略的SWOT分析
    Summary Shanxi Sanwei Group Co., Ltd (SSGC) is an organic chemical product manufacturer that offers products such as VAE Emulsion, white emulsion, re-dispersible emulsion powder, sodium diacetate, gamma butyrolactone, poly tetra methylene glycol, tetrahydrofuran, 1,4-butanediol,and polyvinyl alcohol …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆